News Detail
New Delhi, 25 May 2022: The Subject Expert Committee (SEC) of the country’s drug regulator has recommended granting permission to multinational drug major Eli Lilly to import and market anti cancer drug selpercatinib capsules in 40 mg and 80 mg dosages, subject to condition......
View Details
Source : Pharmabiz
Related News
- China-manufactured vaccines turn out ineffective amid rising Covid cases (26-06-2022)
- Vigilance raids on drug inspector yield crores in Bihar (26-06-2022)
- Kickback charges return to haunt India’s drug regulator (25-06-2022)
- Chemists in Maharashtra districts with high Covid cases to keep records of self-test kit buyers (25-06-2022)
- Domestic pharma sale declines 6.3% for second consecutive month in row (25-06-2022)
- PIL filed on illegal sale of antibiotics (25-06-2022)
- Calcutta HC Orders Mandatory Videography in All Cases of Recovery of Narcotics (25-06-2022)
- Delhi HC stops 2 pharma companies from using 'LOOZOUT' trademark (25-06-2022)
- In Rajasthan Sale-Purchase data of NDPS drugs will have to be uploaded on the portal (24-06-2022)
- Govt to transfer Narcotic Drugs and Psychotropic Substance Act from FinMin to MHA (24-06-2022)